Clinical Trial Update: Adalimumab in Adult Japanese Subjects With Moderate to Severe Chronic Plaque Psoriasis [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update shows that Phase 2 and Phase 3 studies of adalimumab in adult Japanese patients with moderate to severe chronic plaque psoriasis have co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: Abbott | Conditions: Psoriasis | Phase 2, Phase 3 | Status: COMPLETED